VEGFC and Alzheimer disease: AD-VEGF-C-treatedmice had significantly higher DAI scores from the second day of treatment compared toDSS-treated mice (P=0.046 on day 2, P=0.002 on day 3, P=0.003 on day 4, andP<0.001 afterwards) (Figure 1A).VEGF-C156S-treated mice also had significantly higher DAI scores on days 3, 5, 6 and7 compared to PBS-treated mice (all P≤0.046; Figure1B).